Morgan Stanley analyst Greg Parrish downgrades Stride (NYSE:LRN) from Overweight to Equal-Weight and announces $46 price target.
Where Definitive Healthcare Stands With Analysts
Within the last quarter, Definitive Healthcare (NASDAQ:DH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…